Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2

European Neuropsychopharmacology

Volumn 12, Issue 3, 2002, Pages 261-268

  Rehavi, Moshe ^a   Roz, Netta ^a   Weizman, Abraham ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Clozapine; Dopamine transporter; Haloperidol; Noradrenaline transporter; Serotonin transporter; Vesicular monoamine transporter

Indexed keywords

CARRIER PROTEIN; CLOZAPINE; DIHYDROTETRABENAZINE; DOPAMINE; HALOPERIDOL; MESSENGER RNA; MONOAMINE; NORADRENALIN; SEROTONIN; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; SYNAPSE;

ANIMALS; ANTIPSYCHOTIC AGENTS; BINDING SITES; BIOLOGICAL TRANSPORT; BRAIN; BRAIN CHEMISTRY; CLOZAPINE; DRUG ADMINISTRATION SCHEDULE; FLUOXETINE; HALOPERIDOL; IN SITU HYBRIDIZATION; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NEUROPEPTIDES; PAROXETINE; PIPERAZINES; RATS; TETRABENAZINE; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 0036234096     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(02)00021-4     Document Type: Article

References (36)

1. Biogenic amine transporters: Regulation in flux
2. Clozapine, haloperidol and the D4 antagonist PNU-101387G: In vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release
3. Positive and negative symptoms to clozapine in schizophrenic patients with and without the deficit syndrome
4. New antipsychotic agents: Emerging clinical profiles
5. Schizophrenia
6. 125I]iodoketan-serine
7. Functional identification and molecular cloning of a human brain vesicle monoamine transporter
8. Expression cloning of a reserpine-sensitive vesicular monoamine transporter
9. Molecular analysis of vesicular amine transporter function and targeting to secretory organelles
10. Synaptic vesicular monoamine transporter expression: Distribution and pharmacological profile
11. 3H]imipramine localization and relationship to serotonin transporter
12. 2 receptors in rat brain: An autoradiographic study
13. The role of nucleus accumbens dopamine in motivated behavior: A unifying interpretation with special reference to reward-seeking
14. Pharmacologic treatment of schizophrenia
15. Membrane transporters
16. +
17. Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and the shell of the nucleus accumbens
18. 3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum
19. The role of serotonin in antipsychotic drug action
20. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: Impact on risk-benefit assessment
21. 3H]GBR-12395
22. Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra
23. Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen
24. Posttranscriptional regulation of GAP-43 gene expression in PC-12 cells through protein kinase C-dependent stabilization of the mRNA
25. Regulation of rat brain vesicular monoamine transporter by chronic treatment with ovarian hormones
26. Vesicular neurotransmitter transporters: From bacteria to humans
27. 3H]Nisoxetine: A radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding
28. Differential quantal release of histamine and 5-hydroxytryptamine from mast cells of vesicular monoamine transporter 2 knockout mice
29. The vesicular monoamine transporter is not regulated by dopaminergic drugs treatment
30. Synaptotagmin IV is an immediate early gene induced by depolarization in PC12 cells and in brain
31. Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain
32. The effects of clozapine on aggression and substance abuse in schizophrenic patients
33. Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain
34. How does a vesicle know it is full?
35. The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat